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A B S T R A C T
Background: To study the effects of two different structured
shared care interventions, tailored to local needs and
resources, in an unselected patient population with type 2
diabetes mellitus. 
Methods: A three-year prospective observational study of
two interventions and standard care. The interventions
involved extensive (A) or limited (B) task delegation from
general practitioners to hospital-liaised nurses specialised
in diabetes and included a diabetes register, structured
recall, facilitated generalist-specialist communication,
audit and feedback, patient-specific reminders, and
emphasised patient education. The target population
consisted of 2660 patients with type 2 diabetes treated in
the primary care setting. Patients who were terminally ill
or who had been diagnosed with dementia were excluded
from the study. 
Results: The participation rates were high (90%) for
patients, and none of the 64 GPs discontinued their
participation in the study. Longitudinal analyses showed
significant improvements in quality indicators for both
intervention groups (process parameters and achieved
target values on the individual patient level); in standard
care, performance remained stable or deteriorated.
Both patients and caregivers appeared satisfied with the
project.
Conclusion: This study shows that structured shared
care with task delegation to nurses, targeted at a large
unselected general practice population, is feasible and
can positively affect the quality of care for patients with
type 2 diabetes.
I N T R O D U C T I O N
Type 2 diabetes mellitus (type 2 DM) is a chronic disease,
which leads to considerable morbidity and premature
mortality.1,2 The prevalence of type 2 DM is high and is
increasing.3 Since most patients with diabetes die from
complications of atherosclerosis, they should receive
intensive preventive interventions to reduce their cardio-
vascular risk.4 Guidelines for clinical practice have been
developed in many countries to optimise diabetes care.5,6
However, the implementation of these guidelines has not
been straightforward.7,8 There are many reasons for this,
including a lack of time, recall facilities and diabetes
registers, staffing problems, poor quality of documentation,
the unavailability of qualified nurses, problems with
patient compliance, inadequate reimbursement, lack of
physician consultative assistance, and long waiting lists
for ophthalmologists.9,10
As in other countries, in the Netherlands the care for
type 2 DM patients is concentrated in the primary care
setting,6,11 and there is a growing shortage of primary
healthcare providers.12,13
Structured shared care can partially resolve the afore-
mentioned problems and may also improve the quality of
care for patients with diabetes.14 Multifaceted complex
interventions which target different barriers preventing
change are the most effective. Successful interventions
include applying organisational strategies that increase
structured recall, protecting time which has been reserved
for diabetes care, using multifaceted professional inter-
ventions, facilitating generalist-specialist communication,
delegating tasks to practice assistants or nurses and using
specialist diabetes nurse facilitators. Nurses can play an
important role in encouraging compliance and educating
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patients. In certain situations, they can even replace
physicians in delivering many aspects of diabetes
care.9,10,14-16
Previous studies on diabetes care in general practice
have tended to include highly selected populations of
practitioners and patients.
Our aim was to study the effects of two different forms of
structured shared care, tailored to local needs and
resources, and of standard care in an unselected type 2 DM
patient population in a prospective observational study. 
M A T E R I A L S  A N D  M E T H O D S
Study design
The Zwolle Outpatient Diabetes project Integrating
Available Care (ZODIAC) study investigated the effects of
a shared care project for type 2 DM. In the Netherlands,
general practitioners (GPs) collaborate in GP working
groups. A GP working group consists of several GPs who
practice in the same area or town, and cover for each other
in the delivery of medical services during out-of-office
hours. Eight GP working groups (64 GPs) in the east of
the Netherlands agreed to participate in the study. Three
GPs were excluded from the study, two because they had
recently started a new practice and one due to retirement.
For pragmatic reasons, allocation to the two intervention
groups and to the standard care group was assigned
according to the preference of the GP working groups as
a whole. As Greenhalgh mentioned, it is important to
recognise that the different ways in which GPs organise
their diabetes care and in which they interface with
specialist services is a function of both the particular
needs of their practice populations and their individual
skills and confidence.14 Moreover, for interventions to work,
the methods must be acceptable to the target groups.17
The 32 GPs who participated in intervention A received
extensive support from nurses specialised in diabetes
(DSNs) who were hospital based, but who worked for the
project in the primary care setting. The second group
(intervention B, 21 GPs) received limited support from
DSNs, and the third group (intervention C, 8 GPs), the
standard care group, delivered standard care and received
no extra support. In this project, 1.6 full-time equivalent
DSNs were employed. 
I N T E R V E N T I O N S
Extensive support (intervention A) means that DSNs,
rather than the GPs, performed the annual examination
according to the national guidelines of the Dutch College
of General Practitioners for all the DM patients treated
in the primary healthcare setting. The GPs remained
responsible for the check-ups that should take place every
three months. On top of this, the DSNs gave one-on-one
education, tailored to the needs of the individual patients.
Fundus photography18 was integrated into the consultation
as well, where normally each patient would have been
referred to an ophthalmologist. If necessary (according
to retinal photography results, or in the case of a newly
diagnosed diabetes) a referral to the ophthalmologist was
arranged by the DSN. The appointments with the DSNs
took place outside the hospital in the primary healthcare
setting in the village or city where the patient lived. Any
patient who missed his or her appointment was rescheduled.
Patients who were housebound with serious comorbidity
were visited at home. A comprehensive structured report
of the results was sent to the GP within three weeks. 
If necessary, the results were accompanied by recommen-
dations from the DSN concerning referrals to a dietician,
chiropodist, and/or podiatrist, and by a recommendation
from an internist concerning treatment (according to the
guidelines). This process allowed the GPs to dedicate
their consultation time to discussing the results with the
patient in detail, and to decide how to act upon them.
The GPs kept the full responsibility for the care of the
patients and were not under any obligation to follow the
recommendations they were given. A second part of the
extensive support structure was the possibility of sending
individual patients directly to the DSN for an on-demand
consultation within the primary healthcare setting (without,
as in standard care, a formal referral to secondary care).
Possible reasons for requesting such a consultation could
be for patient education, instruction on self-monitoring, or
instruction on insulin injection. The GPs were responsible
for determining the initial insulin dosages and for making
any dosage changes. 
The only extraneous support the GPs in intervention
group B received was having direct access to on-demand
consultations with the DSN, without the need for a formal
referral to secondary care. They performed the annual and
three-monthly check-ups themselves, including making
any necessary referrals to the ophthalmologist.
In the standard care group (8 GPs), patient care was
delivered as usual, with no extra support. Consultation
with a DSN was only possible through a formal referral to
the internist in the secondary healthcare setting. 
All participating GPs received one-time feedback about
their baseline performance, which was discussed within
the GP working group in the presence of an internist.
Patients
The target population consisted of patients with type 2
diabetes who were being treated in the primary care setting,
and the aim was to have an unselected population.
Virtually all citizens of the Netherlands are registered
with a GP. Annually, the GPs provided lists with the
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names of all the patients who were known to have type 2
diabetes, as defined by the guidelines of the Dutch
College of General Practitioners.6 Patients with type 1
diabetes were excluded. Type 1 diabetes was defined by
age at diagnosis <40 years and a requirement for insulin
within one month of diagnosis. A total of 155,774 persons
were registered with the 61 participating GPs, 3362 of
whom had been diagnosed with type 2 diabetes mellitus.
Patients were only excluded if they were being treated in
secondary care by an internist, if they were terminally ill,
or if they had been diagnosed with severe dementia. 
Data collection
We collected data on all the eligible patients with type 2
DM who were registered with and were treated by the 61
GPs, during the three consecutive years from 1998 to
2000. The data were collected annually for all patients
from the (electronic and/or paper) patient records in the
general practice (including correspondence with specialists)
by the principal investigator of the study. Additionally,
data were collected by the investigator from the reports
on the consultations by the DSNs in the intervention
groups A and B. 
The data were collected on full medical history, micro-
vascular and macrovascular complications, diabetes and
other medication(s), referrals for ophthalmological
examination, measurements of blood pressure and
weight, foot examination, smoking status, and laboratory
measurements: HbA1c, total cholesterol, HDL cholesterol,
triglycerides, creatinine, microalbuminuria, and albumin-
creatinine ratio in urine (reference value for HbA1c 4.0 to
6.0%). The blood pressure was measured by the DSN in
intervention group A, and by the GP in intervention group
B and in the standard care group. The blood pressure was
measured twice with a Welch Allyn Sphygmomanometer
in the supine position after at least five minutes of rest.
Renal clearance was calculated by the Cockroft and Gault
formula.19 The data on patient and provider satisfaction
were collected by asking the GP ‘How do you judge the
shared care project?’ and ‘How do your patients judge the
shared care project?’ The Medical Ethics Committee of
the Isala Clinics (formerly Weezenlanden Hospital)
approved this study. 
Outcome measurements
The effects of the interventions were measured by
changes in three quality indicators. We studied (1) process
control (the percentage of patients with examinations and
measurements performed according to the guidelines),
and (2) outcome control (the percentage of patients who
achieved target values: HbA1c <7.0%, blood pressure
<150/85 mmHg, total cholesterol <5 mmol/l). Based on
available data, expressing the number of patients known
to have achieved target values as a percentage of the total
target population results in a quality indicator (3) that
combines process and outcome control. The feasibility of
the interventions was evaluated based on the participation
rates of the patients and the GPs and patient and provider
satisfaction. 
Analysis
Statistical analyses were performed using SPSS for
Windows. For baseline cross-sectional analyses we used
Student’s T-test, and the One-way Anova for variables
with a normal distribution, Mann-Whitney-U test for non-
normal variables, and the 2 test for categorical variables.
For longitudinal analyses we performed an ‘intention-
to-treat analysis’ and used the McNemar method. The
different groups were not directly compared with each
other because of the possible bias resulting from the non-
randomised design. 
R E S U L T S
The prevalence of diabetes in the study area was repre-
sentative for a larger area, and the size of the practice
population and the percentage of GPs working in solo-
practices were similarly representative for the population
of the Netherlands. None of the GPs discontinued their
participation in the study. 
Among the 2660 patients with type 2 diabetes treated in
the primary care setting (figure 1), 174 (6.5%) were excluded
by their GPs for reasons of terminal illness or dementia.
Altogether, 2486 patients were eligible for the study: 1244
were assigned to intervention group A, 842 to group B,
and 400 to the standard care group. 
Baseline data are shown in table 1. The three groups differed
significantly at baseline with respect to age, diabetes
duration, glycaemic control, cardiovascular risk factors, and
treatment. Patients who were excluded were older (77.3 vs
68.4 years), had more cerebrovascular complications (23 vs
11%), used significantly less antidiabetic, antihypertensive,
and lipid-lowering medication, and had their eyes (26 vs
55%) and feet (22 vs 36%) examined less frequently com-
pared with participants. 
Out of 2486 patients, 2048 (82%) were available for follow-
up after two years: 217 (8.7%) patients died, 154 (6.2%)
were referred to an internist, 66 (2.7%) moved, and two
patients were lost to follow-up. The referral percentages
to secondary care were 7% for group A, 4% for B, and
9% for the standard care group. The follow-up for the
different groups was 77% for intervention A, 88% for
intervention B and 79% for the standard care group. In
intervention A, 1121 (90.1%) of patients responded to the
invitation for a consultation with the DSN at least twice
during the three years of the project, and 33 (2.7%) were
excluded by the GP after initially participating. 
Ubink-Veltmaat, et al. Shared care with task delegation to nurses.
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Figure 1
Selection of patients with type 2 diabetes treated in primary care, assignment to the interventions in the ZODIAC
study, and follow-up between 1998 and 2001
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Baseline data from patients with type 2 diabetes treated in primary care in intervention groups A and B, and standard care
group C (means or percentages), 1998/1999
INTERVENTION GROUP STANDARD CARE 
A B C TOTAL P VALUE*
Practice characteristics
Gender GPs male (%) 88 85 100 89 0.52
Practice size 2612 2523 2732 2598 0.51
Prevalence DM (%) 1.9 2.3 2.4 2.1 0.09
Patients (N) 1127 842 400 2369
Gender female (%) 58 54 60 57 0.07
Age (years) 68.7 67.3 70.3 68,5 <0.001
Diabetes duration (years) 7.7 6.7 6.5 7.2 0.002
HbA1c (%) 7.5 7.3 7.3 7.4 0.01
BMI (kg/m2) 28.9 28.0 26.7 28.8 0.01
Systolic blood pressure(mmHg) 155 150 152 153 <0.001
Diastolic blood pressure (mmHg) 84 83 84 84 0.15
Total cholesterol (mmol/l) 5.7 5.5 5.9 5.7 0.003
Total cholesterol/HDL ratio 5.3 5.2 5.0 5.2 0.25
Diabetes treatment
Diet (%) 13 20 10 15 <0.001
Oral agent (%) 70 64 75 69
Insulin (%) 14 12 12 13
Insulin and oral agent (%) 2 5 3 3
*Single test for statistically significant differences between A, B, and C.
M A R C H  2 0 0 5 ,  V O L .  6 3 ,  N O .  3
Ubink-Veltmaat, et al. Shared care with task delegation to nurses.
106
The opportunity to consult with a DSN on-demand was
not frequently used. The reasons for these consultations
were, in the majority of cases, for support with respect to
education and instruction of insulin therapy within the
primary care setting: 27/47 (57%) for group A and 11/19
(58%) for group B.
The effects of the interventions are shown in tables 2 and 3.
Table 2 shows the change in process control. Performance
significantly improved with respect to process parameters
for both interventions A (extensive support by DSNs) and
B (limited support by DSNs): at two-year follow-up, all
examinations and measurements were performed more
frequently for group A, and most for B. In intervention A,
where the DSN is responsible for the annual check-up,
the performance was very high, ranging from 84 to 90%;
for intervention B this ranged from 18 to 85%. In the
standard care group, the performance regarding process
parameters remained stable or decreased, ranging from
2 to 72% for the various parameters after two years of
follow-up. Table 3 shows the change in outcome control:
Ubink-Veltmaat, et al. Shared care with task delegation to nurses.
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Table 3
Quality indicators for the treatment of patients with type 2 diabetes treated in primary care in intervention groups A
and B, and standard care group C in 1998/1999 and 2000/2001
PROCESS OUTCOME CONTROL PROCESS AND OUTCOME 
CONTROL BASELINE FOLLOW-UP P VALUE DIRECTION OF CONTROL COMBINED
GROUP (%) (%) (%) CHANGE# (%)*
HbA1c ≤7.0% A 89 43 42 0.76 - 37 (350/963)
B 75 46 48 1.0 - 36 (264/737)
C 63 50 42 0.03 ↓ 27 (84/314)
Blood pressure A 88 40 52 <0.001 ↑ 46 (439/963)
≤150/85 mmHg B 85 47 51 0.02 ↑ 44 (321/737)
C 72 43 42 0.92 - 30 (95/314)
Total cholesterol A 89 28 40 <0.001 ↑ 35 (341/963)
≤5 mmol/l B 63 33 49 <0.001 ↑ 31 (227/737)
C 39 26 26 0.27 - 10 (32/314)
*Known achieved target values in the total population (%); #p<0.05.
Table 2
Performance with respect to process control in the treatment of patients with type 2 diabetes treated in primary care in
intervention groups A and B, and standard care group C in 1998/1999 and 2000/2001
BASELINE (%) FOLLOW-UP (%) P VALUE DIRECTION OF SIGNIFICANT CHANGE
Foot examination A 44 87 <0.001 ↑
B 31 41 <0.001 ↑
C 16 11 0.11 -
Eye examination A 48 84 <0.001 ↑
B 57 67 <0.001 ↑
C 41 53 0.001 ↑
HbA1c A 57 89 <0.001 ↑
B 67 75 <0.001 ↑
C 62 63 0.91 -
Blood pressure A 76 88 <0.001 ↑
B 89 85 0.03 ↓
C 78 72 0.03 ↓
Total cholesterol A 46 89 <0.001 ↑
B 59 63 0.06 -
C 48 39 0.008 ↓
Creatinine A 54 89 <0.001 ↑
B 63 74 <0.001 ↑
C 60 63 0.33 -
Body mass index A 0.3 88 <0.001 ↑
B 0.3 18 <0.001 ↑
C 0.6 2 0.45 -
Smoking status known A 5 90 <0.001 ↑
B 25 41 0.001 ↑
C 7 11 0.001 ↑
performance regarding the percentage of patients who
achieved target values for the different groups. The per-
centage of patients with good glycaemic regulation
remained stable in intervention groups A and B, and
decreased in the standard care group. For both blood
pressure and hypercholesterolaemia, outcome control
improved in intervention groups A and B, while there
was no change in the standard care group. Based on the
available data, expressing the number of patients known
to have achieved target values as a percentage of the total
target population results in a quality indicator that com-
bines process and outcome control. It appears that the
performance for this quality indicator was 35 to 46% for
intervention A, 31 to 44% for intervention B, and 10 to
30% for the standard care group. 
The GPs rated the project as good in 70 and 69% of cases
and adequate in 30 and 25% of cases in interventions A
and B, respectively; the patients were satisfied in 81% of
cases according to their GPs. There was no mention of
dissatisfaction. 
D I S C U S S I O N
In this study, examining two interventions with structured
shared care and task delegation, which was targeted at an
unselected group of patients with type 2 diabetes treated
in a primary care setting, we found improvements in
process and outcome control. Performance for process
parameters increased for both interventions, as did the
percentage of achieved target values on the individual
patient level for blood pressure and total cholesterol, but
not for blood glucose control. In contrast, the standard
care group showed minimal improvements, and even
some deterioration. The patient participation rate
remained high throughout the study, and none of the
GPs discontinued participation. 
Strengths and limitations
A strong point of this study is that the results may, for the
most part, be generalised to similar patient populations.
We studied a highly unselected patient population, unlike
many of the previous studies on this topic. The quality of
care improved even though changes are difficult to effect in
busy primary care environments.20 The interventions used
in this study may be used in other primary care settings,
provided the same exclusion criteria are applied.
Excluding those terminally ill or having dementia seems
realistic from a clinical point of view: intensive therapy is
either not useful for prevention of long-term complications
or not possible.21
A limitation of our study is the nonrandomised design.
To study how evidence and guidelines may be translated
into daily practice, flexibility is necessary to deal with
pragmatic issues; rigorous nonrandomised study designs
including quasi-experimental, time series and observational
studies are sometimes more appropriate.22 We chose, for
pragmatic reasons, to assign the patients to the intervention
groups according to the preferences of the GP working
groups. The effects of the interventions may have been
overestimated as a consequence of the design,23 and base-
line values were not comparable for the three groups
analysed. Direct comparison would consequently be difficult
to interpret. We therefore decided to limit our analysis to
independent descriptions of the three intervention groups,
and focussed on the quality indicators at the individual
patient level instead of on group means. At the same
time, there was a difference in the amount of available
data: in group A the data collected during consultations
with the patients by the DSNs were nearly complete. In
groups B and C, however, the data were collected from
the GPs’ patient records, where the availability of data
was not optimal. Obtaining data provided from medical
records can lead to underreporting of care delivered.24
However, although the same lack of documentation has
been found by others,20,25 and intermediate outcomes
may not be different for the patients concerned,25 the
negligent recording of risk factors reflects suboptimal
care, because opportunities to detect increased risk and
therefore to start treatment are missed. Moreover, the
quality of care delivered lacks transparency. 
Comparison with other studies
With intervention A (extensive support by DSNs) a large
increase was found with respect to process control, with
an overall high performance rate between 84 and 90%,
which is higher than that found in another recent study
(41 to 80%).25 This appears to be a direct effect of the
central role of the DSNs who were responsible for per-
forming the annual check-up. For intervention B (limited
support by DSNs), process control improved as well, and
was comparable with, or higher than (but still suboptimal)
the findings reported by Goudswaard et al.25 The standard
care group showed few improvements, and even some
deterioration. Renders et al. reported a similar finding for
their reference group.26
For outcome control (achieved target values), in both
intervention groups the percentage of patients achieving
target values increased for blood pressure regulation and
lipid control. Although difficult to compare, other inter-
vention studies with a central role for DSNs showed
improvement in blood pressure and/or lipid profile as
well,27-29 whereas programmes without a central role for
DSNs found no (significant) positive effect on these
outcomes.26,30 In the standard care group no changes in
outcome control for blood pressure or hypercholesterol-
aemia were found.
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In the intervention groups we did not find an increase in
the percentage of patients with good glycaemic regulation,
whereas other intervention programmes did.27,29-32 The
percentage of patients with an HbA1c <7 is comparable or
somewhat lower compared with that found by others.26,30,32
An explanation for the lack of improvement may be that
the baseline HbA1c was already quite acceptable in this
unselected population, which may have left little room
for improvement (ceiling effect).33 The GPs in all three
participating groups treat a higher percentage (80%) of
the total diabetic population in primary care than in most
other programmes (61 to 75%),26,34,35 probably also including
a higher percentage of patients who are difficult to treat.
Since metabolic control tends to deteriorate with the
duration of the disease,36 keeping glycaemic control stable
could be seen as a positive effect of the interventions. In
the standard care group, the percentage of patients with
good glycaemic regulation decreased, which was also
reported by De Sonnaville et al. for their control group.30
Using a quality indicator that combines process and
outcome control may be a simple and transparent
method to indicate the quality of care delivered, enabling
benchmarking of performance at the level of the individual
health care providers or teams.
In intervention group A, 9.9% of patients did not visit
the DSN in either one of the three project years. This
percentage seems acceptable as it is within the variance
(0 to 17%) that is mentioned in a Dutch literature study
into diabetes patients not showing up within a period of
6 to 13 months.37 Reasons mentioned by patients varied
between ‘just don’t want to’ and ‘long-term admittance to
the hospital’ or ‘partner to ill’ or ‘family problems’. Many
patients who could not participate in one year resumed
participation in the next year. 
The follow-up period may have been too short to show all
the potential positive effects, since the GPs only started to
make more use of on-demand consultations after two years.
We expect that the intervention groups and the standard
care group will diverge further with respect to the quality
of care as, in intervention group A, the recommendations
from the internists become increasingly stringent and
extensive at the GPs’ request. Moreover, we are currently
seeing a large annual increase in on-demand consultations
in intervention groups A and B.
Implications
Abnormal but unrecorded values deprive the GP of possible
indications for starting or adjusting treatment, and may
therefore hamper the achievement of optimal diabetes
care at the individual patient level. Moreover, unrecorded
values limit the transparency of the care delivered. In
other healthcare settings, quality indicators have yet to be
included in the assessment of the quality of diabetes care.38
Although there have been proposals,39,40 in the Netherlands
there is not yet an official set of quality indicators, while
this would be useful for benchmarking and to compare
effect evaluations of interventions to improve the quality
of diabetes care. 
The delegation of tasks to nurses appears to improve
process control, as process indicators improved and
reached high levels when nurses were responsible for
performing the annual check-ups. Concomitantly, outcome
control appears to improve at the level of individually
reached target values. 
Ultimate proof of the effectiveness of these interventions
can only be seen after analysing the development of
complications as was done recently by Gaede et al.41
The ZODIAC study has now entered its seventh year
which will make the assessment of long-term effects of
the presented interventions possible within the next
few years.
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